{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"spastic-ataxia-dysarthria-due-to-glutaminase-deficiency","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"A rare genetic neurometabolic disease characterized by childhood onset of global developmental delay, progressive spastic ataxia leading to loss of independent ambulation, and elevated plasma levels of glutamine. Optic atrophy, tremor, and dysarthria have also been reported. Brain imaging may show cerebellar atrophy.","mondoId":"MONDO:0034146","node":{"canonicalSlug":"spastic-ataxia-dysarthria-due-to-glutaminase-deficiency","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Spastic ataxia-dysarthria due to glutaminase deficiency","originalSourceId":"ORPHA:557056","paragraphs":["A rare genetic neurometabolic disease characterized by childhood onset of global developmental delay, progressive spastic ataxia leading to loss of independent ambulation, and elevated plasma levels of glutamine. Optic atrophy, tremor, and dysarthria have also been reported. Brain imaging may show cerebellar atrophy."],"rawAttribution":"ORPHA:557056","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:43:24Z","upstream":"ORPHA:557056","url":"https://rarediseases.info.nih.gov/diseases/22247"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"autosomal recessive spastic ataxia","mondoId":"MONDO:0017847","slug":null},{"kind":"parent","label":"glutaminase deficiency","mondoId":"MONDO:0600001","slug":"glutaminase-deficiency"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/22247\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:557056</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare genetic neurometabolic disease characterized by childhood onset of global developmental delay, progressive spastic ataxia leading to loss of independent ambulation, and elevated plasma levels of glutamine. Optic atrophy, tremor, and dysarthria have also been reported. Brain imaging may show cerebellar atrophy.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/22247\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"spastic-ataxia-dysarthria-due-to-glutaminase-deficiency","sourceDocuments":[{"name":"GARD: Spastic ataxia-dysarthria due to glutaminase deficiency","reviewed":null,"source_release":"2026-10-25T03:43:24Z","url":"https://rarediseases.info.nih.gov/diseases/22247"}],"sourceNote":"","synonyms":[],"takeawayHtml":"","title":"spastic ataxia-dysarthria due to glutaminase deficiency"},"schemaVersion":1}
